These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18398226)

  • 21. Cognitive consequences and central nervous system injury following treatment for childhood leukemia.
    Moore IM; Espy KA; Kaufmann P; Kramer J; Kaemingk K; Miketova P; Mollova N; Kaspar M; Pasvogel A; Schram K; Wara W; Hutter J; Matthay K
    Semin Oncol Nurs; 2000 Nov; 16(4):279-90; discussion 291-9. PubMed ID: 11109272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic value of black seed oil in methotrexate hepatotoxicity in Egyptian children with acute lymphoblastic leukemia.
    Hagag AA; AbdElaal AM; Elfaragy MS; Hassan SM; Elzamarany EA
    Infect Disord Drug Targets; 2015; 15(1):64-71. PubMed ID: 25809628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA; Reaman GH; MacLean WE; Sather HN; Whitt JK
    Cancer; 1999 Apr; 85(8):1859-65. PubMed ID: 10223582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
    Pääkkö E; Harila-Saari A; Vanionpää L; Himanen S; Pyhtinen J; Lanning M
    Med Pediatr Oncol; 2000 Nov; 35(5):456-61. PubMed ID: 11070477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
    Zając-Spychała O; Pawlak MA; Karmelita-Katulska K; Pilarczyk J; Derwich K; Wachowiak J
    Neuroradiology; 2017 Feb; 59(2):147-156. PubMed ID: 28074235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
    Li Y; Vijayanathan V; Gulinello M; Cole PD
    Pharmacol Biochem Behav; 2010 Jun; 95(4):428-33. PubMed ID: 20332001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.
    Waber DP; Tarbell NJ; Fairclough D; Atmore K; Castro R; Isquith P; Lussier F; Romero I; Carpenter PJ; Schiller M
    J Clin Oncol; 1995 Oct; 13(10):2490-6. PubMed ID: 7595698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
    Aytaç S; Yetgin S; Tavil B
    Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Oxidant Defense, Apoptosis, and Cognitive Abilities During Treatment for Childhood Leukemia.
    Moore IMK; Koerner KM; Gundy PM; Montgomery DW; Insel KC; Harris LL; Taylor OA; Hockenberry MJ
    Biol Res Nurs; 2018 Jul; 20(4):393-402. PubMed ID: 29514461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
    Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
    Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.
    Ki Moore IM; Gundy P; Pasvogel A; Montgomery DW; Taylor OA; Koerner KM; McCarthy K; Hockenberry MJ
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e86-93. PubMed ID: 25222054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation.
    Mulhern RK; Fairclough D; Ochs J
    J Clin Oncol; 1991 Aug; 9(8):1348-56. PubMed ID: 2072138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal methotrexate overdose.
    Lee AC; Wong KW; Fong KW; So KT
    Acta Paediatr; 1997 Apr; 86(4):434-7. PubMed ID: 9174236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study.
    Huisman J; Aukema EJ; Deijen JB; van Coeverden SC; Kaspers GJ; van der Pal HJ; Delemarre-van de Waal HA
    BMC Pediatr; 2008 Jun; 8():25. PubMed ID: 18570650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia.
    Rubnitz JE; Relling MV; Harrison PL; Sandlund JT; Ribeiro RC; Rivera GK; Thompson SJ; Evans WE; Pui CH
    Leukemia; 1998 Aug; 12(8):1176-81. PubMed ID: 9697870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
    Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
    Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.